Skip to main content

황기태 교수

Hwang, Ki-Tae

서울대학교 외과학교실 · 생화학·유전·분자생물학

연구실 소개

황기태 교수의 연구실은 유방암의 분자적 특성과 예후 인자에 중점을 두고 있으며, 특히 호르몬 수용체 상태, HER2 표현형, BCL2, KRAS, RUNX3 등 다양한 유전자 및 분자 마커의 임상적 예측 가능성을 규명하고자 합니다. 또한 전임상적 및 임상 데이터를 기반으로 한 유전자 복수 변화(복수 번복) 분석을 통해 전이 위험도를 예측하는 생물학적 모델을 개발하고 있습니다. 이는 개인 맞춤 치료 전략 수립에 기여할 수 있는 핵심 연구 분야입니다.

유방암 예후 인자분자 마커복수 번복 분석KRASRUNX3

연구 현황

논문 수
208
총 인용 수
2,005
최근 5년 논문
45
주요 분야
생화학·유전·분자생물학

연구 성과 추이

표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.

5개년 연도별 논문 게재 수
45총합
2021
2022
2023
2024
2025
5개년 연도별 피인용 수
203총합
20212022202320242025

주요 논문

15
1
논문|인용수 182·2018
Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database
Ki‐Tae Hwang, Jong-Jin Kim, Jiwoong Jung, Ji Hyun Chang, Young Jun Chai, So Won Oh, Sohee Oh, Young A Kim, Sung Bae Park, Kyu Ri Hwang
SJR Q1FWCI 4.1Clinical Cancer Research

Breast cancer subtype was a significant independent prognostic factor regarding both BCSS and OS in multivariable analyses. HRc(+) subtypes showed better prognosis compared with HRc(-) subtypes regarding both BCSS and OS. HRc(-)/HER2(+) showed better prognosis than HRc(-)/HER2(-) but worse prognosis than HRc(+) subtypes regarding both BCSS and OS. The triple-negative subtype showed the worst BCSS compared with the other subtypes irrespective of race, age, or stage.

Cancer ResearchBiochemistry, Genetics and Molecular Biology
2
논문|인용수 76·2017
Prognostic Influence of Preoperative Fibrinogen to Albumin Ratio for Breast Cancer
Ki‐Tae Hwang, Jung Kee Chung, Eun Youn Roh, Jong-Jin Kim, Sohee Oh, Young A Kim, Jiyoung Rhu, Suzy Kim
SJR Q2FWCI 3.2Journal of Breast CancerOA

Preoperative FAR was a strong independent prognostic factor in breast cancer. Its prognostic effect was more prominent in the stage II/III subgroup and in the luminal A-like subtype. Therefore, preoperative FAR can be utilized as a useful prognosticator for breast cancer patients. Further studies are needed to validate its applications in clinical settings.

OncologyMedicine
3
논문|인용수 61·2012
Prognostic influence of BCL2 expression in breast cancer
Ki‐Tae Hwang, Jung Woo Woo, Hee-Chul Shin, Han‐Suk Kim, Soo Kyung Ahn, Hyeong‐Gon Moon, Wonshik Han, In Ae Park, Dong‐Young Noh
SJR Q1FWCI 2.3International Journal of CancerOA

Although BCL2 has occasionally been suggested as a candidate prognostic factor for breast cancer, it is still not accepted as a prognostic factor. We attempted to validate the role of BCL2 as a prognostic factor of breast cancer. Data on 7,230 primary breast cancer patients from the Seoul National University Hospital Breast Care Center were analyzed. Three current prognostic models, including the St. Gallen model, the Nottingham prognostic index (NPI) model and the TNM model, were used for analy

Cancer ResearchBiochemistry, Genetics and Molecular Biology
4
논문|인용수 46·2008
Genomic copy number alterations as predictive markers of systemic recurrence in breast cancer
Ki‐Tae Hwang, Wonshik Han, Jihyoung Cho, Jong Won Lee, Eunyoung Ko, Eun‐Kyu Kim, So‐Youn Jung, Eun‐Mi Jeong, Ji‐Yeon Bae, Jason Kang, Song‐Ju Yang, Sungwon Kim
SJR Q1FWCI 3.4International Journal of Cancer

We tried to establish models that predict systemic recurrence in breast cancer by selecting marker clones with DNA copy number alterations (CNAs) using an array comparative genomic hybridization (CGH). Array CGH containing 4,044 human bacterial artificial chromosome clones was used to assess CNAs in 62 primary breast cancer tissues from 31 patients with systemic recurrence within 5 years after surgery and clinicopathologically well matched 31 patients who had no evidence of disease for at least

GeneticsBiochemistry, Genetics and Molecular Biology
5
논문|인용수 29·2019
Prognostic Role of <i>KRAS</i> mRNA Expression in Breast Cancer
Ki‐Tae Hwang, Byoung Hyuck Kim, Sohee Oh, So Yeon Park, Jiwoong Jung, Jong-Jin Kim, In Sil Choi, Sook Young Jeon, Woo‐Young Kim
SJR Q2FWCI 0.8Journal of Breast CancerOA

<i>KRAS</i> mRNA expression was significantly associated with breast cancer prognosis. It was found to be an independent prognostic factor for breast cancer. Prognostic role of <i>KRAS</i> mRNA expression was effective only in luminal A subtype. Further studies are needed to validate the prognostic role of <i>KRAS</i> mRNA expression in breast cancer, thus paving a way for clinical application of <i>KRAS</i> in practice.

Cancer ResearchBiochemistry, Genetics and Molecular Biology
6
논문|인용수 28·2007
Downregulation of the RUNX3 Gene by Promoter Hypermethylation and Hemizygous Deletion in Breast Cancer
Ki‐Tae Hwang, Wonshik Han, Ji-Yeon Bae, Sung Eun Hwang, Hyuk Jai Shin, Jeong Eon Lee, Sung Won Kim, Hyun Jung Min, Dong‐Young Noh
SJR Q2FWCI 0.8Journal of Korean Medical ScienceOA

The RUNX3 gene is regarded as a tumor suppressor gene in many human solid tumors, and its inactivation is believed to be related with solid tumor carcinogenesis. As little information is available about the role of the RUNX3 gene in breast cancer, we investigated the relationship between the RUNX3 gene and breast cancer. We performed reverse transcriptase-polymerases chain reaction (RT-PCR), methylation specific PCR, and bicolor fluorescent in situ hybridization analysis in an effort to reveal r

HematologyMedicine
7
논문|인용수 26·2017
Prognostic Influence of BCL2 on Molecular Subtypes of Breast Cancer
Ki‐Tae Hwang, Wonshik Han, Jong-Jin Kim, Hyeong‐Gon Moon, Sohee Oh, Yun Seon Song, Young A Kim, Mee Soo Chang, Dong‐Young Noh
SJR Q2FWCI 1.6Journal of Breast CancerOA

The prognostic influence of BCL2 was different across molecular subtypes of breast cancer, and it was largely dependent on HR, HER2, Ki-67, and the stage of cancer. BCL2 had a strong favorable prognostic impact only in HR(+)/HER2(-) or luminal A and luminal B/HER2(-) subtypes, particularly in advanced stages. Further investigations are needed to verify the prognostic influence of BCL2 on molecular subtypes of breast cancer and to develop clinical applications for prognostication using BCL2.

OncologyMedicine
8
논문|인용수 26·2017
Poor Prognosis of Lower Inner Quadrant in Lymph Node–negative Breast Cancer Patients Who Received No Chemotherapy: A Study Based on Nationwide Korean Breast Cancer Registry Database
Ki‐Tae Hwang, Jong-Jin Kim, Eun‐Kyu Kim, Sung Hoo Jung, Guiyun Sohn, Seung Il Kim, Joon Jeong, Kyu Eun Lee, Jin Hyun Park, Sohee Oh, Sei Hyun Ahn, Dong‐Young Noh
SJR Q2FWCI 0.8Clinical Breast CancerOA
Cancer ResearchBiochemistry, Genetics and Molecular Biology
9
논문|인용수 25·2020
Influence of Androgen Receptor on the Prognosis of Breast Cancer
Ki‐Tae Hwang, Ki‐Tae Hwang, Young A Kim, Jong-Jin Kim, Jeong Hwan Park, In Sil Choi, Kyu Ri Hwang, Kyu Ri Hwang, Young Jun Chai, Jin Hyun Park
SJR Q1FWCI 1.4Journal of Clinical MedicineOA

We investigated the prognostic influence of androgen receptor (AR) on breast cancer. AR status was assessed using immunohistochemistry with tissue microarrays from 395 operable primary breast cancer patients who received curative surgery. The Kaplan-Meier estimator was used to analyze the survival rates and a log-rank test was used to determine the significance of the differences in survival. The Cox proportional hazards model was used to calculate the hazard ratio (HR) and the 95% confidence in

Cancer ResearchBiochemistry, Genetics and Molecular Biology
10
논문|인용수 20·2020
Validating the ACOSOG Z0011 Trial Result: A Population-Based Study Using the SEER Database
Jiwoong Jung, Byoung Hyuck Kim, Jong-Jin Kim, Sohee Oh, Su‐jin Kim, Chang-Sup Lim, In Sil Choi, Ki‐Tae Hwang
SJR Q1FWCI 1.2CancersOA

The Z0011 trial demonstrated that axillary lymph node dissection (ALND) could be omitted in spite of 1-2 metastatic sentinel lymph nodes. This study aimed to validate the results on a population-based database. The Surveillance, Epidemiology, and End Results (SEER) database was searched for patients comparable to the Z0011 participants. The type of axillary surgery was estimated using the total number of examined axillary lymph nodes (ALNs). Breast cancer-specific mortality (BCSM) was compared b

Cancer ResearchBiochemistry, Genetics and Molecular Biology
11
논문|인용수 19·2017
The influences of peritumoral lymphatic invasion and vascular invasion on the survival and recurrence according to the molecular subtypes of breast cancer
Ki‐Tae Hwang, Young A Kim, Jong-Jin Kim, A Jung Chu, Ji Hyun Chang, So Won Oh, Kyu Ri Hwang, Young Jun Chai
SJR Q1FWCI 0.5Breast Cancer Research and Treatment
Cancer ResearchBiochemistry, Genetics and Molecular Biology
12
논문|인용수 19·2017
BCL2 Regulation according to Molecular Subtype of Breast Cancer by Analysis of The Cancer Genome Atlas Database
Ki‐Tae Hwang, Kwangsoo Kim, Ji Hyun Chang, Sohee Oh, Young A Kim, Jong Yoon Lee, Se Hee Jung, In Sil Choi
SJR Q1FWCI 0.9Cancer Research and TreatmentOA

The regulation of BCL2 was mainly associated with methylation across the molecular subtypes of breast cancer, and luminal A and luminal B subtypes showed upregulated expression of BCL2 protein, mRNA, and hypomethylation. Although copy number alteration may have played a minor role, mutation status was not related to BCL2 regulation. Upregulation of BCL2 was associated with superior prognosis than downregulation of BCL2.

Cancer ResearchBiochemistry, Genetics and Molecular Biology
13
논문|인용수 18·2021
Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer
Ki‐Tae Hwang, Young A Kim, Jong-Jin Kim, Hyeon Jeong Oh, Jeong Hwan Park, In Sil Choi, Jin Hyun Park, Sohee Oh, A Jung Chu, Jong Yoon Lee, Kyu Ri Hwang
SJR Q1FWCI 0.8Scientific ReportsOA

We investigated the prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer patients. BCL1 and BCL2 expression statuses were assessed by immunohistochemistry using tissue microarrays from 393 breast cancer patients. The Kaplan-Meier estimator and log-rank test were used for survival analyses. The Cox proportional hazards model was used to calculate hazard ratio (HR) and the 95% confidence interval (CI) of survival analyses. BCL1 expression revealed no impact o

OncologyMedicine
14
논문|인용수 15·2020
Influence of Metabolic Syndrome on Risk of Breast Cancer: A Study Analyzing Nationwide Data from Korean National Health Insurance Service
Ki‐Tae Hwang, Kyungdo Han, Sohee Oh, Bo Kyung Koo, Se Kyung Lee, Jong-Jin Kim, Hwa Jeong Seo, Jiwoong Jung, Byoung Hyuck Kim, Ho Hur
SJR Q1FWCI 1.1Cancer Epidemiology Biomarkers & Prevention

Abstract Background: To investigate the influence of metabolic syndrome and its components on the risk of breast cancer. Methods: Retrospective nationwide cohort study analyzing data of 13,377,349 women older than 19 years from Korean National Health Insurance Service was performed. Cox proportional hazards model was used to calculate HR and 95% confidence interval (CI) of breast cancer risk. Results: The presence of metabolic syndrome decreased the risk of all breast cancer types in all subject

Molecular BiologyBiochemistry, Genetics and Molecular Biology
15
논문|인용수 11·2019
Modification of Mosquitto Broker for Delivery of Urgent MQTT Message
Ki‐Tae Hwang, Jae Moon Lee, In Hwan Jung, Dong-Hee Lee
FWCI 2.02019 IEEE Eurasia Conference on IOT, Communication and Engineering (ECICE)

This paper proposes a new method to expand the functions of the MQTT so that it may transmit urgent messages first. The Mosquitto, the widely used as a standard MQTT broker has been chosen and modified in order to create a “U-Mosquitto” broker capable of processing urgent messages. Several experiments have been conducted to verify the performance of the U-Mosquitto. Having analyzed the delivery time of the messages, it was observed that the more publishers, urgent messages were delivered faster

Media TechnologyEngineering

대표 연구 분야

Cancer ResearchOncologySurgeryComputer Networks and CommunicationsGeneticsMolecular Biology

황기태 교수의 연구를 Nubint에서 더 깊이 살펴보세요

이 연구실의 논문을 앱에서 열어 AI와 함께 읽고, 핵심을 요약하고, 내 글에 인용하세요.